MoffittRadOnc (@moffittradonc) 's Twitter Profile
MoffittRadOnc

@moffittradonc

Product of your friendly local Moffitt Radiation Oncology Residents. Highlighting departmental news, successes, research, events.

ID: 1162468887939702785

linkhttps://bit.ly/2OZkoEg calendar_today16-08-2019 21:01:48

544 Tweet

936 Followers

485 Following

Drew Moghanaki 🐕 (@drewmoghanaki) 's Twitter Profile Photo

A research team at MoffittRadOnc led by Tom Dilling publishes the largest series evaluating Surgery and SBRT for stage I SCLC. The report contains valuable data about adjuvant chemotherapy and PCI for this population. #radonc sciencedirect.com/science/articl…

A research team at <a href="/MoffittRadOnc/">MoffittRadOnc</a> led by <a href="/tom_dilling/">Tom Dilling</a> publishes the largest series evaluating Surgery and SBRT for stage I SCLC. The report contains valuable data about adjuvant chemotherapy and PCI for this population. #radonc  sciencedirect.com/science/articl…
Moffitt Cancer Center (@moffittnews) 's Twitter Profile Photo

We are thrilled to announce that Moffitt Cancer Center has once again been named the #1 Cancer Hospital in Florida and the Southeast by Newsweek! Congratulations to everyone at Moffitt for this outstanding achievement!

We are thrilled to announce that Moffitt Cancer Center has once again been named the #1 Cancer Hospital in Florida and the Southeast by <a href="/Newsweek/">Newsweek</a>!

Congratulations to everyone at Moffitt for this outstanding achievement!
MoffittRadOnc (@moffittradonc) 's Twitter Profile Photo

Excited to announce our upcoming Virtual Meet & Greet session! If you are a medical student interested in learning more about Moffitt Rad Onc, please sign up at the link below. Sign up link: docs.google.com/spreadsheets/d…

Excited to announce our upcoming Virtual Meet &amp; Greet session! 

If you are a medical student interested in learning more about Moffitt Rad Onc, please sign up at the link below.

Sign up link: docs.google.com/spreadsheets/d…
Inna Smalley 🇺🇦 (@innasmalley) 's Twitter Profile Photo

Kamran Ahmed giving a great summary of the Phase II Study of Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in the Management of HER2+ Breast Leptomeningeal Disease. A collaborative effort with Peter Forsyth Moffitt Cancer Center and Priya Kumthekar. #snoasco24

<a href="/KAhmedMD/">Kamran Ahmed</a> giving a great summary of the Phase II Study of Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in the Management of HER2+ Breast Leptomeningeal Disease. A collaborative effort with <a href="/PeterForsyth27/">Peter Forsyth</a> <a href="/MoffittNews/">Moffitt Cancer Center</a> and Priya Kumthekar. #snoasco24
JAMA Oncology (@jamaonc) 's Twitter Profile Photo

Radiation therapy followed by intrathecal trastuzumab and pertuzumab for HER2+ breast leptomeningeal disease is safe with initial intracranial control results that appear encouraging. ja.ma/4fAaPDY Kamran Ahmed Moffitt Cancer Center

Radiation therapy followed by intrathecal trastuzumab and pertuzumab for HER2+ breast leptomeningeal disease is safe with initial intracranial control results that appear encouraging. ja.ma/4fAaPDY <a href="/KAhmedMD/">Kamran Ahmed</a> <a href="/MoffittNews/">Moffitt Cancer Center</a>
ASTRO (@astro_org) 's Twitter Profile Photo

Congratulations to Hsiang-Hsuan Michael Yu, MD, ScM, on becoming a 2024 ASTRO Fellow! View the complete list of the 2024 Fellows here: ow.ly/RAaY50SIn49

Congratulations to Hsiang-Hsuan Michael Yu, MD, ScM, on becoming a 2024 ASTRO Fellow! View the complete list of the 2024 Fellows here: ow.ly/RAaY50SIn49
MoffittRadOnc (@moffittradonc) 's Twitter Profile Photo

TOMORROW‼️‼️👀👀 If you are a medical student interested in learning more about Moffitt Rad Onc, please sign up at the link below. Sign up link: docs.google.com/spreadsheets/d…

TOMORROW‼️‼️👀👀

If you are a medical student interested in learning more about Moffitt Rad Onc, please sign up at the link below.

Sign up link: docs.google.com/spreadsheets/d…
Moffitt Cancer Center (@moffittnews) 's Twitter Profile Photo

Tomorrow at #WCLC24: Moffitt’s Thomas Dilling, MD (Tom Dilling) presents a machine learning analysis of cardiac doses and survival in NSCLC chemoradiotherapy during the e-poster session. ⏰: 9/7 Learn more ➡️ bit.ly/4e4CStS

Tomorrow at #WCLC24: Moffitt’s Thomas Dilling, MD (<a href="/tom_dilling/">Tom Dilling</a>) presents a machine learning analysis of cardiac doses and survival in NSCLC chemoradiotherapy during the e-poster session.

⏰: 9/7 
  Learn more ➡️ bit.ly/4e4CStS